Phase II study of gemcitabine, carboplatin and veliparib in multiple relapsed/refractory germ cell tumors (GCTs).

Michal Mego,Daniela Svetlovska,Maria Reckova,Katarina Kalavska,Jana Obertova,Patrik Palacka,Katarina Rejlekova,Valentina De Angelis,Zuzana Sycova-Mila,Michal Chovanec,Jozef Mardiak

Phase II study of gemcitabine, carboplatin and veliparib in multiple relapsed/refractory germ cell tumors (GCTs).

2021

Michal Mego
Daniela Svetlovska
Maria Reckova
Katarina Kalavska
Jana Obertova
Patrik Palacka
Katarina Rejlekova
Valentina De Angelis
Zuzana Sycova-Mila
Michal Chovanec
Jozef Mardiak

e17009Background: GCTs represent a model for the cure of cancer. Nonetheless, a small proportion of patients develop disease recurrence. PARP is overexpressed in GCTs compared to normal testis and ...

Keywords:

Gemcitabine
Medicine
Veliparib
Phases of clinical research
Germ cell tumors
relapsed refractory
Cancer
Cancer research
Carboplatin

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations